“…This last finding could be related to the more aggressive tumor characteristics highlighted in the USNB-positive patients. In accordance with what has been reported in other studies (20,24,26), in the present study this cohort of patients had more aggressive tumor characteristics as well. Larger tumor size, estrogens receptor negativity, HER-2 amplification, high Ki-67 proliferation index, high histological grade and extranodal invasion were significantly higher when compared to the SLNB-positive group.…”